Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice.
Invariant NKT (iNKT) cells are innate-like lymphocytes that recognize glycolipid antigens in the context of the MHC class I-like antigen-presenting molecule CD1d. In vivo activation of mouse iNKT cells with the glycolipid alpha-galactosylceramide (alpha-GalCer) results in the acquisition of a hyporesponsive (anergic) phenotype by these cells. Because iNKT cells can become activated in the context of infectious agents, here we evaluated whether iNKT cell activation by microorganisms can influence subsequent responses of these cells to glycolipid antigen stimulation. We found that mouse iNKT cells activated in vivo by multiple bacterial microorganisms, or by bacterial LPS or flagellin, became unresponsive to subsequent activation with alpha-GalCer. This hyporesponsive phenotype of iNKT cells required IL-12 expression and was associated with changes in the surface phenotype of these cells, reduced severity of concanavalin A-induced hepatitis, and alterations in the therapeutic activities of alpha-GalCer. These findings may have important implications for the development of iNKT cell-based therapies.
Kim
Sungjune
S
Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
Lalani
Saif
S
Parekh
Vrajesh V
VV
Vincent
Tiffaney L
TL
Wu
Lan
L
Van Kaer
Luc
L
D000818:Animals; D004926:Escherichia coli / Q000378:metabolism; D005408:Flagellin / Q000378:metabolism; D005699:Galactosylceramides / Q000378:metabolism*; D018664:Interleukin-12 / Q000378:metabolism; D015847:Interleukin-4 / Q000378:metabolism; D007694:Killer Cells, Natural / Q000378:metabolism / Q000382:microbiology*; D007700:Kinetics; D008070:Lipopolysaccharides / Q000378:metabolism; D008214:Lymphocytes / Q000378:metabolism / Q000382:microbiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008954:Models, Biological; D010641:Phenotype
D005699:Galactosylceramides; D008070:Lipopolysaccharides; C493154:alpha-galactosylceramide; D005408:Flagellin; D018664:Interleukin-12; D015847:Interleukin-4